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Gold has been used in medicine for thousands of years. Nowadays, gold compounds contribute to the
treatment of rheumatoid arthritis; gold alloys are used in implants in various ﬁelds of medicine; and
colloid gold is used in immunogold electron microscopy. Advances in nanotechnology have resulted in
novel gold nanoparticles, which possess distinct physical properties such as ﬂuorescence. We have
developed ﬂuorescent gold nanoclusters (FANCs) that contain gold nanoparticles with a core dimension
< 2 nm. Initial studies have shown that FANCs are a highly biocompatible marker with a ﬂuorescence
half-life of 9 days, and are suitable for in vitro and in vivo tracking of endothelial and endothelial
progenitor cells. FANCs may also have novel chemical properties involved in regulation of endothelial cell
function. This minireview discusses the future directions of biomedical research for FANCs.
Copyright  2012, Taiwan Society of Geriatric Emergency & Critical Care Medicine. Published by Elsevier
Taiwan LLC. All rights reserved.1. Introduction
Gold has been known to humans for more than 5000 years.
Owing to its rarity and vivid color that is maintained without
oxidization in air or water, gold is considered a symbol of fortune to
its owners and has been used in coinage, jewelry and ornaments,
and other art works. Later, the malleable, ductile and nontoxic
properties brought gold into dentistry for use in tooth restoration.
In modern medicine, implants made of gold alloys have been
used in a variety of medical ﬁelds other than dentistry, including
eyelid closure, middle ear reconstruction, and voice prostheses1. In
these cases, the high biocompatibility of gold with minimal tissue
reaction is an important advantage. In addition, gold is used in
biomedical research. In immunogold electron microscopy colloidal
gold particles are conjugated to antibodies to detect speciﬁc anti-
gens for visualizing their location. Apart from implants and
research tools, gold has pharmacological effects.
2. Pharmacological effects of gold
Gold was considered to be a precious drug and had multiple
beneﬁcial health effects in ancient times. In an important book of
Tao entitled Bauputz, the author, Hung Kir (283e363 AD) stated:erest.
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).
iwan Society of Geriatric Emergen“ingest gold to live a gold-like longevity”. Traditional Chinese
medicine has used gold to treat palpitations, seizures, and skin
infection. Nowadays gold leaf, ﬂake or dust is used on or in some
foods and drinks, however, the purpose is only for decoration.
Although there is no evidence that the gold leaf, ﬂake or dust is
absorbed by the body, a recent study of zebra ﬁsh exposed to gold
nanoparticles of two sizes (12 nm and 50 nm) at very low doses
(36e106 ng gold/ﬁsh/day) showed alteration of genome composi-
tion, as well as expression of genes involved in DNA repair, detox-
iﬁcation processes, apoptosis, mitochondrial metabolism, and
oxidative stress. These data suggest the toxicity of long-term low-
dose gold exposure2. In addition, gold ions do have pharmacolog-
ical effects. In patients with rheumatoid arthritis, gold ions have
been used to reduce joint pain for nearly 80 years3. Several gold
compounds have been developed for parenteral or oral adminis-
tration. Among these, gold sodium thiomalate has been the most
extensively studied4. For this purpose, gold compounds can be used
alone or in combination with other drugs. In a recent randomized,
double-blind, double-observer, placebo-controlled multicenter trial
(the METGO study) in rheumatoid arthritis patients with a subop-
timal response to methotrexate, adding weekly intramuscular gold
caused signiﬁcant clinical improvement5. The mechanisms are not
fully understood but attenuation of inﬂammation in the diseased
joints is though to play a major role. In vitro studies have shown that
gold ions inhibit T lymphocyte activation and antigen presentation6,
as well as inhibit overproduction of proinﬂammatory cytokines,
cyclooxygenase expression, and prostaglandin E2 production incy & Critical Care Medicine. Published by Elsevier Taiwan LLC. All rights reserved.
Fig. 1. Duration of FANCs in EPCs. After 4 hours of FANC delivery, medium and FANCeliposome complexes were replaced with fresh medium. Cells were trypsinized and subject to
ﬂow cytometry at indicated time points. The ﬂuorescence distribution proﬁle and mean ﬂuorescence intensity of control cells (liposome only) and cells loaded with 500 nmol/L
FANCs are shown in black and red, respectively. The relative ﬂuorescence intensity of FANCs compared to liposomes only was calculated. During the period of maintenance, medium
was changed every 2 days. EPC¼ endothelial progenitor cell; FANC¼ ﬂuorescent gold nanocluster.
H.-H. Wang et al.2macrophages7. Interestingly, whether the anti-inﬂammatory effect
of gold ions occurs at the cell membrane or requires entrance of
gold into the cytoplasm remains unclear. Different compounds
may vary in their effects. Concern has been raised about long-term
use, for example, immune suppression may occur after adminis-
tration of auranoﬁn, an oral gold compound4.
In patient with coronary artery disease undergoing percuta-
neous balloon angioplasty with stenting, inhibition of inﬂamma-
tion after stent placement has been demonstrated to be an effective
way to attenuate neointima formation and hence prevent in-stent
restenosis. The anti-inﬂammatory effect of gold has been tested.
Clinical studies comparing gold-coated stainless steel stents with
uncoated bare stents showed worse outcome in the gold-coated
stent group8. This implies that other effects of gold promoting in-
stent restenosis outweigh the anti-inﬂammatory properties.
3. Distinct physical properties of gold nanoparticles
Although colloidal gold particles used in immunogold electron
microscopy are nanoparticles, the size is rarely < 5 nm. Recentadvances in nanotechnology have paid attention to gold nano-
particles < 2 nm. Such a small size renders the behavior of gold
intermediates between that of atoms and nanoparticles (> 2 nm),
with alteration of various fundamental properties9. For example,
gold nanoparticles show a size-dependent plasmon absorption
band when their conduction electrons are conﬁned to dimensions
smaller than the electron mean free path length (w20 nm)10.
However, gold nanoparticles < 2 nm no longer possess plasmon
resonance and Mie’s theory no longer can be applied11e13. Instead,
when the size goes down to the Fermi wavelength of electrons
(w0.7 nm), the gold nanoparticles possess molecule-like properties
including size-dependent ﬂuorescence and discrete size-dependent
electronic states. The ﬂuorescent properties of gold nanoparticles
make them potential labels in biomedical research. Initial studies
showed that most thiol-related gold nanoclusters protected by
glutathione14, tiopronin15, meso-2,3-dimercaptosuccunic acid16,
and phenylethylthiolate17, emit ﬂuorescence ranging from red to
infrared red. However, the quantum yield was reported at < 1% and
was not bright enough for the nanoclusters to be of interest as
ﬂuorochromes. Recently, we used bovine serum albumin as the
Table 2
Comparison of FANC and quantum dot for biomedical application.
FANC Quantum dots
Core Gold Cadmium selenide,
cadmium sulﬁde, or
indium arsenide
Size 2e20 nm 5e50 nm
Quantum yield 7% 30e50%
Fluorescence stabilitya Less photobleaching Much less photobleaching
Application of Gold in Biomedicine 3template and reductant to develop a novel water-soluble ﬂuores-
cent gold nanocluster (FANC) with negatively charged surface
modiﬁcation, unique optical properties, and a higher quantum yield
(w2%)18. The quantum yield is even improved after thermal treat-
ment (up to 7%)19. The FANC has high colloidal stability, and can be
readily conjugated with biological molecules. The core diameter of
the FANC is < 2 nm. In addition, FANCs with different modiﬁca-
tions20 are able to emit blue, green and red ﬂuorescence.Cytotoxicity Suitable for long-term
labeling
Highly toxic
Environmental impact
at synthesis and usage
Environmental friendly Toxic byproducts
Biomedical application Feasible Restricted by the nature
of toxic heavy metal
FANC¼ ﬂuorescent gold nanocluster.
a Compare to traditional ﬂuorescent dyes.4. FANCs are biocompatible markers for In Vitro and In Vivo
tracking
To date, FANCs have been successfully used to label primary
cultured cells, including human aortic endothelial cells and endo-
thelial progenitor cells (EPCs)19. For both types of cells, simple
addition of FANCs in the culturemedium followed by incubation for
several hours delivers the FANCs into the cells. However, the ﬂuo-
rescence is notbright enough for clear visualization.With thehelp of
liposome complexes, up to 1000 nmol/L of FANC can be effectively
delivered. Theﬂuorescence at 500 nmol/L is strong and can be easily
detected by both ﬂuorescence microscopy and ﬂow cytometry. In
addition, it lasts for at least 28 days. Measurement of the ﬂuores-
cence byﬂowcytometry has shown that the half-life is nearly 9 days
in vitro (Fig. 1). Whether such a strong ﬂuorescence is associated
with cytotoxicity has been tested by a series of comprehensive
examinations (Table 1). Only vascular cell adhesion molecule 1 and
vascular endothelial cadherin were downregulated at a high
concentration (500 nmol/L). Otherwise, therewasneitheractivation
of apoptosis nor proliferation, nor change of cell viability, unless >
500 nmol/L, at which level, there was a minor reduction in viability
due to liposomes. For human EPCs, no impairment of angiogenesis
was seen in vitro. In an in vivo study using hindlimb ischemia, mice
with intramuscular administration of FANC-labeled human EPCs
showed that the cells preserved angiogenic potential and exhibited
traceable signals after 21 days. These ﬁndings demonstrated that
FANCs are promising biocompatible ﬂuorescent probes.
With such a high biocompatibility and not being toxic to the
environment, the future of FANCs for labeling is promising, and if
the quantum yields can be further improved, FANCs may totally
replace quantum dots, which possess intrinsic toxicity for living
cells and the environment, although the latter have strongerTable 1
Effects of FANC on expression proﬁles and function of human aortic endothelial cells
and endothelial progenitor cells.
Effect Unchanged
mRNA level Downregulation of
VCAM and VE-Cad
Ang-1, Cx43, eNOS, PAI-1, VEGF,
KDR, ZO-1, JAM-1, IL-8, MMP-9
Protein level Cx43, PAI-1, eNOS, VE-Cad,
KDR, caspase-3, PCNA
Cytotoxicity Occurs above
500 nmol/L
Labeling using
liposome
> 98% efﬁciency and
130-fold induction of
ﬂuorescence intensity
at 500 nmol/L
Angiogenic activity
(in vitro)
Tube formation in Matrigel
Angiogenic activity
(in vivo)
Limb salvage (hindlimb
ischemic mice)
Ang-1¼ angiopoietin 1; Cx43¼ connexin 43; eNOS¼ endothelial nitric oxide
synthase; FANC¼ ﬂuorescent gold nanocluster; IL-8¼ interleukin 8; JAM-1¼
junctional adhesion molecule 1; KDR¼ kinase insert domain receptor; MMP-9¼
matrix metallopeptidase 9; PAI-1¼ plasminogen activator inhibitor 1; PCNA¼
proliferating cell nuclear antigen; VCAM¼ vascular cell adhesion molecule;
VE-Cad¼ vascular endothelial cadherin; VEGF¼ vascular endothelial growth factor;
ZO-1¼ zona occludens 1.ﬂuorescence intensity (quantum yields 30e50%). Table 2 compares
the properties of FANCs and quantum dots for biomedical
applications.
5. Unresolved issues of FANCs
Although FANCs are effectively delivered into cells with the help
of liposome complexes, their location in the cells is not clear.
Immunoconfocal microscopy shows that FANCs inside cells are
away from the cell membrane and only a few are co-localized
with endosomes or lysosomes. In addition, FANCs are not found
in the cell nucleus. Questions that remain are: (1) how are FANCs
metabolized? (2) what are the mechanisms underlying the decay of
ﬂuorescence? (3) Does the decay of ﬂuorescence parallel the
removal of FANC from the cells? Further investigation is required to
clarify these issues.
6. Other potential application of FANCs in biomedicine
Existing knowledge is helpful to guide the direction of research
for future applications of gold compounds. Examples have been
demonstrated in traditionalmedicine forproviding clues21. Theanti-
inﬂammatory properties of gold compounds used for treatment of
rheumatoid arthritismayalso exist in FANCs. The ﬁnding that FANCs
downregulate vascular cell adhesion molecule 1 and vascular
endothelial cadherin is consistent with this view, because expres-
sion of both molecules is known to attract inﬂammatory cells22. In
contrast, negatively charged poly(acrylic acid)-conjugated gold
nanoparticles have been reported to bind to and induce unfolding of
ﬁbrinogen, which promotes activation of macrophage receptor 1
(Mac-1) and the nuclear factor-kB signaling pathway, resulting in
the release of inﬂammatory cytokines23. These data indicate the
presence of cell-type-speciﬁc effects of gold nanoparticles, and that
the molecules conjugated to gold nanoparticles play an important
role in determining the properties. Gold nanoparticle treatment has
been reported to induce oxidative-stress-mediated genomic insta-
bility in lung ﬁbroblasts24. Furthermore, calcined gold has been
reported to attenuate stress-elicited neuroendocrine hyperac-
tivity25. Whether FANCs possess all the properties requires clariﬁ-
cation in the future. However, from a practical point of view, the
metabolismof FANCs and their interactionwith cell organelles, such
as in human aortic endothelial cells and EPCs, have a higher priority,
to understand the biomedical effects of FANCs.
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